PMDA drug package insert
ツムラ漢方内服液麦門冬湯S
PMDA OTC drug · （株）ツムラ · package insert Dec 20, 2022
Key facts
| Brand names | ツムラ漢方内服液麦門冬湯S |
|---|---|
| Companies | 製造販売元／新生薬品工業（株）・奈,販売会社／（株）ツムラ |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 液剤 |
| OTC effect category | 麦門冬湯 |
| Package insert date | Dec 20, 2022 |
| PMDA document key | 340268_K1308000012 |
| PMDA company code | 340268 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: